IL103305A0 - Cardioprotective tocopherol analogs - Google Patents

Cardioprotective tocopherol analogs

Info

Publication number
IL103305A0
IL103305A0 IL103305A IL10330592A IL103305A0 IL 103305 A0 IL103305 A0 IL 103305A0 IL 103305 A IL103305 A IL 103305A IL 10330592 A IL10330592 A IL 10330592A IL 103305 A0 IL103305 A0 IL 103305A0
Authority
IL
Israel
Prior art keywords
cardioprotective
tocopherol analogs
tocopherol
analogs
benzopyrans
Prior art date
Application number
IL103305A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL103305A0 publication Critical patent/IL103305A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Credit Cards Or The Like (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Cosmetics (AREA)
  • Noodles (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Fire-Detection Mechanisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IL103305A 1991-10-02 1992-09-30 Cardioprotective tocopherol analogs IL103305A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91402630A EP0535283A1 (de) 1991-10-02 1991-10-02 Tocopherol Analoge mit kardioprotektiver Wirkung

Publications (1)

Publication Number Publication Date
IL103305A0 true IL103305A0 (en) 1993-02-21

Family

ID=8208620

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103305A IL103305A0 (en) 1991-10-02 1992-09-30 Cardioprotective tocopherol analogs

Country Status (17)

Country Link
EP (2) EP0535283A1 (de)
JP (1) JP3230699B2 (de)
KR (1) KR100253108B1 (de)
AT (1) ATE163421T1 (de)
AU (1) AU652077B2 (de)
CA (1) CA2079289C (de)
DE (1) DE69224501T2 (de)
DK (1) DK0536036T3 (de)
ES (1) ES2115656T3 (de)
FI (1) FI105552B (de)
GR (1) GR3026242T3 (de)
HU (1) HU215123B (de)
IL (1) IL103305A0 (de)
NO (1) NO923840L (de)
NZ (1) NZ244549A (de)
TW (1) TW224970B (de)
ZA (1) ZA927429B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
WO1999026582A2 (en) * 1997-11-25 1999-06-03 University Of Otago Mitochondrially targeted compounds
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
AU2002317053B2 (en) 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
ES2314010T3 (es) * 2002-06-19 2009-03-16 Cognis Ip Management Gmbh Empleo de mazclas de principios activos para la obtencion de un medicamento contra la artritis reumatoide.
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
CN1839142B (zh) 2003-08-22 2010-06-16 澳新制药公司 用作靶向线粒体的抗氧化剂的线粒体醌衍生物
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
CA2580584C (en) 2003-09-19 2015-07-28 Galileo Pharmaceuticals, Inc. Use of alpha-tocotrienol for treatment of mitochondrial diseases
CA2557354C (en) 2004-03-03 2013-05-07 Vital Health Sciences Pty Ltd. Alkaloid formulations
MX2007015949A (es) 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
US7813042B2 (en) 2005-09-12 2010-10-12 Sharp Kabushiki Kaisha Multiple-view directional display
WO2008029891A1 (en) 2006-09-07 2008-03-13 Sharp Kabushiki Kaisha Image display device, electronic device, and parallax barrier element
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs
US5500444A (en) 1989-11-14 1996-03-19 Hoechst Marion Roussel, Inc. Cardioprotective tocopherol analogs
US5135945A (en) 1991-06-05 1992-08-04 Merrell Dow Pharmaceuticals Inc. Cholesterol-lowering tocopherol analogs

Also Published As

Publication number Publication date
CA2079289C (en) 2003-02-18
FI924424L (fi) 1993-04-03
JP3230699B2 (ja) 2001-11-19
KR100253108B1 (ko) 2000-05-01
DE69224501D1 (de) 1998-04-02
TW224970B (de) 1994-06-11
GR3026242T3 (en) 1998-05-29
NO923840D0 (no) 1992-10-01
ZA927429B (en) 1993-04-07
HU9203134D0 (en) 1992-12-28
JPH05310763A (ja) 1993-11-22
ES2115656T3 (es) 1998-07-01
AU652077B2 (en) 1994-08-11
DE69224501T2 (de) 1998-06-25
EP0536036A1 (de) 1993-04-07
EP0535283A1 (de) 1993-04-07
FI105552B (fi) 2000-09-15
AU2538392A (en) 1993-04-08
FI924424A0 (fi) 1992-10-01
ATE163421T1 (de) 1998-03-15
DK0536036T3 (da) 1998-03-16
EP0536036B1 (de) 1998-02-25
NO923840L (no) 1993-04-05
HUT62592A (en) 1993-05-28
HU215123B (hu) 1998-09-28
NZ244549A (en) 1994-07-26
CA2079289A1 (en) 1993-04-03

Similar Documents

Publication Publication Date Title
ZA927429B (en) Cardioprotective tocopherol analogs.
HUT66660A (en) Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ZA883444B (de)
EP0291982A3 (en) Cyclic anticoagulant peptides
EP0050286A3 (en) Novel pharmaceutical guanidine derivatives
ZA911994B (en) Novel ascorbic acid derivatives
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
IL101180A0 (en) Indane derivatives,their preparation and their use as fragrance materials
EP0551844A3 (de)
IL95902A0 (en) Prostacyclin derivatives and pharmaceutical compositions containing the same